When Omega Pharma acquired Solpadeine, it set to not only regain, but surpass the product's former market share within the acute pain category. With a complicated formula and mode of action, achieving this sales-turnaround would take a compellingly simple, educative platform.
A 30 second Medifacts commercial, anchored by an independent, pharma-credible third party presenter, and disarmingly simple how-it-works product animation.
The Solpadeine Medifacts commercial aired for 21 weeks and sales increased by 11.1% - the highest market share in 15 years. Today it is the UK's number one pharmacy-only pain relief brand.